Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001123292-25-000081·GILEAD SCIENCES, INC.
Schedule 13G ownership disclosure
IKENA ONCOLOGY INC
Common Stock · CUSIP: 45175G108
Event date: 2024-12-31
- Filing-level shares
- 1,521,312
- Percent of class
- 3.6%
- GILEAD SCIENCES INC
Shares: 1,521,312 · Class: 3.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000081
- Form type
- SCHEDULE 13G/A
- Filer
- GILEAD SCIENCES, INC.
- CIK
- CIK 882095
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership